Literature DB >> 24595887

[Disclosing HIV status: the experience of PLHIV after 10 years of ARV treatment in Senegal].

J Coutherut1, A Desclaux.   

Abstract

Rates of HIV status disclosure observed in Africa, especially to partners, are too low for an optimal implementation of preventive strategies. Access to antiretroviral drugs appears to have facilitated disclosure in the short term, but knowledge is insufficient about long-term practices. A study held with 185 people living with HIV (PLHIV) examined factors associated with disclosure in general and with partners over 10 years of antiretroviral treatment in Dakar. Two third of PLHIV disclosed their status to at least one person, and 56% with their partners. The main results concern factors associated with disclosure to partners (having a child, knowing one's partner status) which are different from factors associated to disclosure in general (duration of ART treatment, secondary or higher education level, being a member of an association). After ten years, 44% of people still living in couple has not disclosed (no significant differences by sex and marital regime). These results invite to regularly offer counselling to PLHIV during follow-up.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595887     DOI: 10.1007/s13149-014-0343-z

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  2 in total

1.  Factors associated with HIV voluntary disclosure of people living with HIV to their steady sexual partner in the Democratic Republic of the Congo: results from a community-based participatory research.

Authors:  Eddy Kieto Zola; Gaspard Matamba Gifudu; Emilie Henry; Adeline Bernier; Henri Mukumbi Masangu; Alise Abadie; Lionel Fugon; Joanne Otis; Marie Préau
Journal:  Pan Afr Med J       Date:  2014-11-14

2.  HIV status disclosure to sexual partners, among people living with HIV and AIDS on antiretroviral therapy at Sokodé regional hospital, Togo.

Authors:  Issifou Yaya; Bayaki Saka; Dadja Essoya Landoh; P'Niwè Massoubayo Patchali; Akouda Akessiwè Patassi; Abdoul-Samadou Aboubakari; Makawa-Sy Makawa; Mathias Kouamé N'Dri; Sékandé Senanou; Bassan Lamboni; Daoudou Idrissou; Kao Tanang Salaka; Palokinam Pitché
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.